BSE filing, NSE: APIS. Summary written from the filing by ALFA Finder's alert engine.
Apis India Ltd: key numbers
- Share price
- ₹52.75
- Market cap
- ₹726.6 Cr
- Revenue (annual)
- ₹390.5 Cr
- Net profit (annual)
- ₹25.32 Cr
- P/E (TTM)
- 29.4×Sector 26.8×
- Promoter holding
- 74.72%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apis India Ltd
All →Apis India Q1 FY27 Results: Net Profit ₹3.4 Cr, Up 36.0% YoY
Apis India Ltd reported revenue from operations of ₹66 Cr (-23.7% YoY) and net profit of ₹3.4 Cr (+36.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.4 Cr · +36.0% YoY
Apis India Board Meeting Date
Apis India will hold its board on 27 Oct 2026 to approve Q1 FY27 unaudited results. The trading window closes until 48 hours post-results declaration.
Apis India Other Announcement
Apis India Ltd filed its quarterly shareholding pattern for the period ending 30 September 2026, pursuant to Regulation 31(1)(b) of the SEBI Listing Regulations.
Apis India Annual General Meeting
Apis India Limited held its 44th Annual General Meeting on September 30, 2026, via video conferencing. Shareholders considered financial statements, director re-appointment, and auditor appointment.
Apis India Promoter Buying (Off-Market)
Promoter Mrs. Sakshi Anand transferred her shareholding to Mr. Amit Anand via an inter-se family gift, duly reported in the quarterly shareholding pattern.
Apis India Price Movement Clarification
Apis India Limited has clarified the delay in submitting its financial results for the quarter ended June 30, 2026, citing pending audit procedures.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.